Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2 AND Treatment
25714 results:

  • 1. Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study.
    Elez E; Cubillo A; Alfonso PG; Middleton MR; Chau I; Alkuzweny B; Alcasid A; Zhang X; Van Cutsem E
    BMC Cancer; 2024 Apr; 24(1):446. PubMed ID: 38600471
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Management and staging of anal adenocarcinoma in the United States: a population-based analysis.
    Troester A; Kohn J; Wang Q; Weaver L; Hassan I; Gaertner W; Marmor S; Goffredo P
    J Gastrointest Surg; 2024 Apr; 28(4):519-527. PubMed ID: 38583905
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical study on simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy for synchronous colorectal cancer liver metastasis.
    Li W; Ren H; Mou H; Li J; Dong L; Li G; Xing M
    J Gastrointest Surg; 2024 Apr; 28(4):425-433. PubMed ID: 38583892
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Vitamin C enhances co-localization of novel TET1 nuclear bodies with both Cajal and PML bodies in colorectal cancer cells.
    El Osmani N; Prévostel C; Picque Lasorsa L; El Harakeh M; Radwan Z; Mawlawi H; El Sabban M; Shirinian M; Dassouki Z
    Epigenetics; 2024 Dec; 19(1):2337142. PubMed ID: 38583183
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Epidemiological and clinicopathological features of KRAS, NRAS, BRAF mutations and MSI in Chinese patients with stage I-III colorectal cancer.
    Wang W; Wang R; Han X; Zhang W; Zhu L; Gu Y
    Medicine (Baltimore); 2024 Apr; 103(14):e37693. PubMed ID: 38579072
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A cross-sectional study of sleep disturbance among middle-aged cancer patients at Vietnam National cancer Hospital.
    Pham AT; Do MT; Tran HTT
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2055. PubMed ID: 38577715
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Long-term outcomes of robot-assisted laparoscopic surgery versus conventional laparoscopic surgery for rectal cancer: single-center, retrospective, propensity score analyses.
    Mazaki J; Ishizaki T; Kuboyama Y; Udo R; Tago T; Kasahara K; Yamada T; Nagakawa Y
    J Robot Surg; 2024 Apr; 18(1):157. PubMed ID: 38568362
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
    Pan QZ; Zhao JJ; Liu L; Zhang DS; Wang LP; Hu WW; Weng DS; Xu X; Li YZ; Tang Y; Zhang WH; Li JY; Zheng X; Wang QJ; Li YQ; Xiang T; Zhou L; Yang SN; Wu C; Huang RX; He J; Du WJ; Chen LJ; Wu YN; Xu B; Shen Q; Zhang Y; Jiang JT; Ren XB; Xia JC
    Signal Transduct Target Ther; 2024 Apr; 9(1):79. PubMed ID: 38565886
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic value of depression and anxiety on colorectal cancer-related mortality: a systematic review and meta-analysis based on univariate and multivariate data.
    Xia S; Zhu Y; Luo L; Wu W; Ma L; Yu L; Li Y
    Int J Colorectal Dis; 2024 Apr; 39(1):45. PubMed ID: 38563889
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. COVID-related disruptions to colorectal cancer screening, diagnosis, and treatment could increase cancer Burden in Australia and Canada: A modelling study.
    Worthington J; Sun Z; Fu R; Lew JB; Chan KKW; Li Q; Eskander A; Hui H; McLoughlin K; Caruana M; Peacock S; Yong JHE; Canfell K; Feletto E; Malagón T
    PLoS One; 2024; 19(4):e0296945. PubMed ID: 38557758
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Furanocoumarin compounds isolated from
    Pengnam S; Jitkaroon W; Srisuphan R; Wongprayoon P; Rayanil KO; Charoensuksai P
    Acta Pharm; 2024 Mar; 74(1):67-79. PubMed ID: 38554381
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Postoperative chemoradiotherapy in patients with locally advanced gastric cancer with poor pathologic response to neoadjuvant chemotherapy.
    Gal O; Lewin R; Perl G; Ulitzky O; Brenner B; Kundel Y
    J Cancer Res Ther; 2024 Jan; 20(1):281-284. PubMed ID: 38554334
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Modified FOLFIRINOX (mFOLFIRINOX) as neoadjuvant therapy and 'salvage' in patients with high risk locally advanced rectal cancers - tolerance and early outcomes.
    Prajapati R; Ostwal V; Srinivas S; Engineer R; Bhargava P; Saklani A; D'Souza A; Kumar S; Peelay Z; Manali P; Ramaswamy A
    J Cancer Res Ther; 2024 Jan; 20(1):199-203. PubMed ID: 38554321
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Ataxia telangiectasia and Rad3-related (ATR) inhibition by VE-822 potently reversed 5-flourouracil resistance in colorectal cancer cells through targeting DNA damage response.
    Mihanfar A; Asghari F; Majidinia M
    Mol Biol Rep; 2024 Mar; 51(1):474. PubMed ID: 38553623
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mechanistic insights into FEN1-mediated drug sensitivity and risk signature in colon cancer: An integrative bioinformatics study.
    Rao C; Tong J; Yang Y
    Medicine (Baltimore); 2024 Mar; 103(13):e37517. PubMed ID: 38552056
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Analysis of the impact of radiotherapy and surgical treatment regimens based on the SEER database on the survival outcomes of rectal cancer patients over 70 years.
    Wang W; Shen T; Wang J
    Math Biosci Eng; 2024 Feb; 21(3):4463-4484. PubMed ID: 38549336
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
    Kim S; Ghiringhelli F; de la Fouchardière C; Evesque L; Smith D; Badet N; Samalin E; Lopez-Trabada Ataz D; Parzy A; Desramé J; Baba Hamed N; Buecher B; Tougeron D; Bouché O; Dahan L; Chibaudel B; El Hajbi F; Mineur L; Dubreuil O; Ben Abdelghani M; Pecout S; Bibeau F; Herfs M; Garcia ML; Meurisse A; Vernerey D; Taïeb J; Borg C
    Lancet Oncol; 2024 Apr; 25(4):518-528. PubMed ID: 38547895
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Early-Onset colorectal cancer in Egypt: Pathological Characters, Patterns of Care, and Survival Compared to Average-Age Onset colorectal cancer: A Retrospective Multicenter Study.
    Rashad N; Eid Salem S; Meheissen MAM; Refaat G; Mahmoud Sami H; Temerik A; Kordy N; Daniel MA; El-Kaffas M; Esam M; El Mansy H; Elkerm Y; Abdelaziz Elsaid A; Attia Ismail A; Saber Abdelhalim M; Moustafa Ahmad L; Akram Mahmoud M; El Desouky ED
    JCO Glob Oncol; 2024 Mar; 10():e2300372. PubMed ID: 38547440
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. colorectal cancer survival disparities in the five regions of Georgia.
    Tsai MH; Cabral DN; Grunert C; Moore JX
    PLoS One; 2024; 19(3):e0301027. PubMed ID: 38547204
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Health Literacy and Demand for Medical Cannabis use among colorectal cancer Patients in Northern Thailand: A Cross-Sectional Study.
    Sukrueangkul A; Sirisuwan P; Anonjarn K; Poungsamai P; Hudrudchai S; Thongkamwong N; Insook P; Suangpho P
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):999-1005. PubMed ID: 38546082
    [TBL] [Abstract] [Full Text] [Related]  


    of 1286.